100.39
price down icon0.44%   -0.44
pre-market  プレマーケット:  99.77   -0.62   -0.62%
loading
前日終値:
$100.83
開ける:
$101.38
24時間の取引高:
699.72K
Relative Volume:
1.10
時価総額:
$4.94B
収益:
$338.46M
当期純損益:
$-310.96M
株価収益率:
-15.37
EPS:
-6.53
ネットキャッシュフロー:
$-132.82M
1週間 パフォーマンス:
-8.47%
1か月 パフォーマンス:
-2.87%
6か月 パフォーマンス:
-2.02%
1年 パフォーマンス:
+16.02%
1日の値動き範囲:
Value
$99.38
$102.15
1週間の範囲:
Value
$99.38
$110.19
52週間の値動き範囲:
Value
$72.21
$139.13

Axsome Therapeutics Inc Stock (AXSM) Company Profile

Name
名前
Axsome Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
(212) 332-3241
Name
住所
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Name
職員
589
Name
Twitter
Name
次回の収益日
2025-02-18
Name
最新のSEC提出書
Name
AXSM's Discussions on Twitter

AXSM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AXSM
Axsome Therapeutics Inc
100.39 4.96B 338.46M -310.96M -132.82M -6.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-03 再開されました Morgan Stanley Overweight
2025-06-03 開始されました Oppenheimer Outperform
2025-04-07 開始されました Jefferies Buy
2025-02-11 開始されました Deutsche Bank Buy
2024-12-31 繰り返されました Mizuho Outperform
2024-09-03 開始されました Wells Fargo Overweight
2024-08-06 アップグレード BofA Securities Neutral → Buy
2024-07-22 開始されました Needham Buy
2024-04-29 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-03-19 開始されました Robert W. Baird Outperform
2024-02-06 開始されました UBS Buy
2024-01-25 開始されました RBC Capital Mkts Outperform
2023-12-13 開始されました Citigroup Buy
2023-08-08 アップグレード BofA Securities Underperform → Neutral
2023-01-05 開始されました Piper Sandler Neutral
2022-11-01 開始されました Loop Capital Buy
2022-09-07 再開されました Mizuho Buy
2021-08-10 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-06-10 開始されました Berenberg Buy
2021-01-08 開始されました Jefferies Buy
2020-12-16 開始されました Mizuho Buy
2020-09-29 開始されました BofA Securities Underperform
2020-09-10 開始されました Morgan Stanley Overweight
2020-04-28 繰り返されました H.C. Wainwright Buy
2020-04-14 開始されました Cowen Outperform
2019-12-30 繰り返されました H.C. Wainwright Buy
2019-12-17 繰り返されました H.C. Wainwright Buy
2019-12-16 繰り返されました Guggenheim Buy
2019-10-16 開始されました Guggenheim Buy
2019-09-18 開始されました William Blair Outperform
2019-05-28 開始されました SunTrust Buy
2019-05-23 繰り返されました H.C. Wainwright Buy
2019-04-08 開始されました SVB Leerink Outperform
2019-03-15 繰り返されました H.C. Wainwright Buy
2016-10-03 再開されました Brean Capital Buy
2015-12-15 開始されました Cantor Fitzgerald Buy
2015-12-14 開始されました Ladenburg Thalmann Buy
すべてを表示

Axsome Therapeutics Inc (AXSM) 最新ニュース

pulisher
Jul 28, 2025

Axsome Therapeutics Inc.’s Price Action Aligns with Quant SignalsTriple Digit Return Stock Predictions Released - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Axsome Therapeutics Inc. stock price move sharplyStock Strategy Planner To Watch Now - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Envestnet Asset Management Inc. Sells 10,086 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Axsome Therapeutics (AXSM) to Release Earnings on Monday - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Axsome Therapeutics Inc. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert guidance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Royce & Associates LP Sells 6,743 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive Axsome Therapeutics Inc. stock higher in 2025Invest confidently with real-time data analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Axsome Therapeutics Inc. stock perform well during market downturnsGet timely alerts on market opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Cwm LLC Trims Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 28, 2025
pulisher
Jul 28, 2025

Y Intercept Hong Kong Ltd Makes New $1.49 Million Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 28, 2025
pulisher
Jul 27, 2025

How strong is Axsome Therapeutics Inc. company’s balance sheetFree Market Dynamics Reports - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Axsome Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Market Query - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 23:41:07 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Axsome Therapeutics Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Axsome Therapeutics Inc. stock expected to show significant growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How does Axsome Therapeutics Inc. generate profit in a changing economyUnprecedented profit potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Knights of Columbus Asset Advisors LLC Sells 4,957 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 27, 2025
pulisher
Jul 26, 2025

Q3 EPS Estimate for Axsome Therapeutics Raised by Analyst - MarketBeat

Jul 26, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics: Navigating Setbacks with a Strong Pipeline and Analyst Confidence - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome: Some Recent Setbacks, Some Recent Wins — Still A Buy (NASDAQ:AXSM) - Seeking Alpha

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.6%Here's Why - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - ADVFN Brasil

Jul 25, 2025
pulisher
Jul 25, 2025

Why Axsome Therapeutics Inc. stock is on top investor watchlistsSuperior stock selection - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Axsome Therapeutics Inc. stockOutstanding capital growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stake Raised by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. - MarketBeat

Jul 25, 2025
pulisher
Jul 24, 2025

RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

New York State Common Retirement Fund Has $3.92 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Is Axsome Therapeutics Inc. stock overhyped or has real potentialUnstoppable trading performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How high can Axsome Therapeutics Inc. stock price go in 2025Breakthrough investment results - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

How To Trade (AXSM) - news.stocktradersdaily.com

Jul 24, 2025
pulisher
Jul 24, 2025

Axsome Therapeutics Settles SUNOSI (Solriamfetol) Patent Litigation With Hetero Labs Ltd. - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Is This Stock a Buy After Soaring by 20% in 1 Day? - AOL.com

Jul 24, 2025
pulisher
Jul 24, 2025

2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 24, 2025
pulisher
Jul 24, 2025

Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today - 富途牛牛

Jul 24, 2025
pulisher
Jul 24, 2025

Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest

Jul 23, 2025
pulisher
Jul 23, 2025

Lindbrook Capital LLC Cuts Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating - TipRanks

Jul 23, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jul 22, 2025

Axsome Therapeutics Inc (AXSM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Axsome Therapeutics Inc (AXSM) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Murdock Hunter R.
General Counsel
Jun 23 '25
Option Exercise
29.91
6,014
179,879
6,014
Murdock Hunter R.
General Counsel
Jun 20 '25
Sale
102.47
7,500
768,525
0
Murdock Hunter R.
General Counsel
Jun 23 '25
Sale
100.12
6,014
602,122
0
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
大文字化:     |  ボリューム (24 時間):